These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7813597)

  • 41. Can insulin-dependent diabetes mellitus be cured or prevented? A status report on immunomodulatory strategies and pancreas transplantation.
    Drash AL; Arslanian SA
    Pediatr Clin North Am; 1990 Dec; 37(6):1467-87. PubMed ID: 2259549
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Future intervention trials in type 1 diabetes.
    Wilkin T; Ludvigsson J; Greenbaum C; Palmer J; Becker D; Bruining J
    Diabetes Care; 2004 Apr; 27(4):996-7. PubMed ID: 15047664
    [No Abstract]   [Full Text] [Related]  

  • 43. Reversal of type 1 diabetes in mice.
    Faustman DL
    N Engl J Med; 2007 Jan; 356(3):311-2. PubMed ID: 17229964
    [No Abstract]   [Full Text] [Related]  

  • 44. Type 1 diabetes mellitus in 2011: Heterogeneity of T1DM raises questions for therapy.
    Pozzilli P
    Nat Rev Endocrinol; 2011 Dec; 8(2):78-80. PubMed ID: 22183128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunotherapy of type I diabetes.
    Kolb H; Greulich B; Kiessel U; Gries FA
    Lancet; 1982 Jul; 2(8289):97-8. PubMed ID: 6123832
    [No Abstract]   [Full Text] [Related]  

  • 46. Immunotherapy of immune-mediated diabetes. Present and future.
    Maclaren N
    Clin Rev Allergy Immunol; 2000 Dec; 19(3):277-97. PubMed ID: 11138410
    [No Abstract]   [Full Text] [Related]  

  • 47. Immune intervention yes, but for what reason, for whom, when and how?
    Lernmark A
    Diabetologia; 1992 Nov; 35(11):1096-8. PubMed ID: 1473622
    [No Abstract]   [Full Text] [Related]  

  • 48. The SAgA of Antigen-Specific Immunotherapy for Type 1 Diabetes.
    Mallone R; You S
    Diabetes; 2021 Jun; 70(6):1247-1249. PubMed ID: 34016601
    [No Abstract]   [Full Text] [Related]  

  • 49. A machine learning approach to predict response to immunotherapy in type 1 diabetes.
    Fousteri G; Rodrigues EM; Giamporcaro GM; Falcone M
    Cell Mol Immunol; 2021 Mar; 18(3):515-517. PubMed ID: 33318626
    [No Abstract]   [Full Text] [Related]  

  • 50. Prologue. Diabetes. An old disease, a new insight.
    Ahmad SI
    Adv Exp Med Biol; 2012; 771():xxvii-xxxiii. PubMed ID: 23393664
    [No Abstract]   [Full Text] [Related]  

  • 51. [Immunotherapy of type 1 diabetes mellitus: current state-of-the-art and prospects. Part 2].
    Laptev DN
    Probl Endokrinol (Mosk); 2009 Oct; 55(5):31-38. PubMed ID: 31569853
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Type 1 diabetes mellitus: immune intervention.
    Skyler JS
    Int J Clin Pract Suppl; 2012 Feb; (175):56-61. PubMed ID: 22308990
    [No Abstract]   [Full Text] [Related]  

  • 53. Immune intervention for type 1 diabetes, 2012-2013.
    Skyler JS
    Diabetes Technol Ther; 2014 Feb; 16 Suppl 1():S85-91. PubMed ID: 24479603
    [No Abstract]   [Full Text] [Related]  

  • 54. Prediabetes in children: natural history, diagnosis, and preventive strategies.
    Kulmala P
    Paediatr Drugs; 2003; 5(4):211-21. PubMed ID: 12662117
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An islet-cell protein tyrosine phosphatase is a likely precursor to the 37-kDa autoantigen in type 1 diabetes: human and macaque sequences, tissue distribution, unique and shared epitopes, and predictive autoantibodies.
    LaGasse J; Jelinek L; Sexson S; Lofton-Day C; Breininger J; Sheppard P; Kindsvogel W; Hagopian WA
    Mol Med; 1997 Mar; 3(3):163-73. PubMed ID: 9100223
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
    Kolb H
    Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
    Bretzel RG
    Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
    [TBL] [Abstract][Full Text] [Related]  

  • 59. New prospects for immunotherapy at diagnosis of type 1 diabetes.
    Pozzilli P; Leslie RD
    Diabetes Metab Res Rev; 2009 May; 25(4):299-301. PubMed ID: 19405079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
    Giannoukakis N; Pietropaolo M; Trucco M
    Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.